Ready to start planning your care? Call us at 833-347-1665 to make an appointment.

Anton Dobrin, BS, MS

Graduate Student

Share

Share

Anton Dobrin

Email

[email protected]

Mentor

Michel Sadelain, MD, PhD

Start Year

2015

Education

BS, University of Toronto; MS, Swiss Federal Institute of Technology Zurich

Fellowships

Geoffrey Beene Graduate Student Fellowship (2016-2017)
Canadian Institutes of Health Research Doctoral Research Award 2017-2020

Publications

Hamieh M, Dobrin A, Cabriolu A, van der Stegen SJC, Giavridis T, Mansilla-Soto J, Eyquem J, Zhao Z, Whitlock BM, Miele MM, Li Z, Cunanan KM, Huse M, Hendrickson RC, Wang X, Rivière I, Sadelain M. (2019) CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape. Nature. 568, 112-116.

Feucht J, Sun J, Eyquem J, Ho YJ, Zhao Z, Leibold J, Dobrin A, Cabriolu A, Hamieh M, Sadelain M. (2018) Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency. Nat Med. [Epub ahead of print].

Dobrin A, Saxena P, Fussenegger M. (2015) Synthetic biology: applying biological circuits beyond novel therapies. Integr Biol (Camb), 8, 409-430. [Epub ahead of print].

Łuksza M, Sethna ZM, Rojas LA, Lihm J, Bravi B, Elhanati Y, Soares K, Amisaki M, Dobrin A, Hoyos D, Guasp P, Zebboudj A, Yu R, Chandra AK, Waters T, Odgerel Z, Leung J, Kappagantula R, Makohon-Moore A, Johns A, Gill A, Gigoux M, Wolchok J, Merghoub T, Sadelain M, Patterson E, Monasson R, Mora T, Walczak AM, Cocco S, Iacobuzio-Donahue C, Greenbaum BD, Balachandran VP. (2022) Neoantigen quality predicts immunoediting in survivors of pancreatic cancer. Nature. Online ahead of print.